Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313408071> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4313408071 endingPage "174.06" @default.
- W4313408071 startingPage "174.06" @default.
- W4313408071 abstract "Abstract Excessive activity of TNF and IL-17 in keratinocytes can drive psoriatic skin inflammation and their targeting is highly advantageous in psoriasis patients, but whether these cytokines act with other inflammatory molecules is unknown. Previously, we demonstrated with knockout mice that the TNF-related cytokine TWEAK (TNFSF12) was a major driver of skin inflammation in the imiquimod model of psoriasis. Here, we found that mice carrying a deletion of TWEAK’s receptor, Fn14 (TNFRSF12A), specifically in keratinocytes, exhibited reduced psoriasis features, including less epidermal hyperplasia and poor expression of genes associated with human psoriasis. Further, RNA-seq analysis in human keratinocytes demonstrated that TWEAK strongly synergizes with either TNF or IL-17A in upregulating the transcripts for psoriasis-associated chemokines and cytokines, implying that TWEAK co-operates with TNF and IL-17 to enhance feedback inflammatory activity. Correspondingly, administration of anti-TWEAK antibody demonstrated therapeutic efficacy in the psoriasis mouse model and was equally as effective as antibodies to IL-17A or TNF in reducing clinical and immunological features of psoriasis-like skin inflammation, while co-neutralization of TWEAK with either cytokine had no additional therapeutic effect, reinforcing the conclusion that all three cytokines act together. We conclude that TWEAK blockade could be another potential therapeutic avenue in patients with psoriasis that might be equally as useful as blocking TNF and IL-17. Future studies targeting TWEAK in clinical trials for psoriasis may then be warranted. Supported by NIH grant AR072640" @default.
- W4313408071 created "2023-01-06" @default.
- W4313408071 creator A5015001776 @default.
- W4313408071 creator A5020769254 @default.
- W4313408071 creator A5030495591 @default.
- W4313408071 creator A5036380790 @default.
- W4313408071 creator A5036973489 @default.
- W4313408071 creator A5051005510 @default.
- W4313408071 creator A5071921789 @default.
- W4313408071 creator A5075170106 @default.
- W4313408071 creator A5085752416 @default.
- W4313408071 date "2022-05-01" @default.
- W4313408071 modified "2023-09-23" @default.
- W4313408071 title "“Therapeutic targeting of tumor necrosis factor like weak inducer of apoptosis (TWEAK) in psoriasis”" @default.
- W4313408071 doi "https://doi.org/10.4049/jimmunol.208.supp.174.06" @default.
- W4313408071 hasPublicationYear "2022" @default.
- W4313408071 type Work @default.
- W4313408071 citedByCount "0" @default.
- W4313408071 crossrefType "journal-article" @default.
- W4313408071 hasAuthorship W4313408071A5015001776 @default.
- W4313408071 hasAuthorship W4313408071A5020769254 @default.
- W4313408071 hasAuthorship W4313408071A5030495591 @default.
- W4313408071 hasAuthorship W4313408071A5036380790 @default.
- W4313408071 hasAuthorship W4313408071A5036973489 @default.
- W4313408071 hasAuthorship W4313408071A5051005510 @default.
- W4313408071 hasAuthorship W4313408071A5071921789 @default.
- W4313408071 hasAuthorship W4313408071A5075170106 @default.
- W4313408071 hasAuthorship W4313408071A5085752416 @default.
- W4313408071 hasConcept C13373296 @default.
- W4313408071 hasConcept C164027704 @default.
- W4313408071 hasConcept C17991360 @default.
- W4313408071 hasConcept C203014093 @default.
- W4313408071 hasConcept C2776914184 @default.
- W4313408071 hasConcept C2778690821 @default.
- W4313408071 hasConcept C2779112978 @default.
- W4313408071 hasConcept C2780564577 @default.
- W4313408071 hasConcept C502942594 @default.
- W4313408071 hasConcept C71924100 @default.
- W4313408071 hasConceptScore W4313408071C13373296 @default.
- W4313408071 hasConceptScore W4313408071C164027704 @default.
- W4313408071 hasConceptScore W4313408071C17991360 @default.
- W4313408071 hasConceptScore W4313408071C203014093 @default.
- W4313408071 hasConceptScore W4313408071C2776914184 @default.
- W4313408071 hasConceptScore W4313408071C2778690821 @default.
- W4313408071 hasConceptScore W4313408071C2779112978 @default.
- W4313408071 hasConceptScore W4313408071C2780564577 @default.
- W4313408071 hasConceptScore W4313408071C502942594 @default.
- W4313408071 hasConceptScore W4313408071C71924100 @default.
- W4313408071 hasIssue "1_Supplement" @default.
- W4313408071 hasLocation W43134080711 @default.
- W4313408071 hasOpenAccess W4313408071 @default.
- W4313408071 hasPrimaryLocation W43134080711 @default.
- W4313408071 hasRelatedWork W1994780675 @default.
- W4313408071 hasRelatedWork W2116137306 @default.
- W4313408071 hasRelatedWork W2153718135 @default.
- W4313408071 hasRelatedWork W2295017376 @default.
- W4313408071 hasRelatedWork W2510134963 @default.
- W4313408071 hasRelatedWork W2560767185 @default.
- W4313408071 hasRelatedWork W2936714595 @default.
- W4313408071 hasRelatedWork W3152882536 @default.
- W4313408071 hasRelatedWork W4319296873 @default.
- W4313408071 hasRelatedWork W4366190430 @default.
- W4313408071 hasVolume "208" @default.
- W4313408071 isParatext "false" @default.
- W4313408071 isRetracted "false" @default.
- W4313408071 workType "article" @default.